Madrigal Pharmaceuticals (MDGL) Q1 2023 Earnings

9MayConfirmed
Aug 22
Nov 22
Q4 2022
Q1 2023
-4.98
-4.55
-4.13
-3.7

Details

Expected EPS
-4.94
Actual EPS
-4.23
Surprise EPS
0.71
Surprise Percent
+14.37%

Description

Madrigal Pharmaceuticals (MDGL) has reported earnings of -4.23 per share for Q1 2023.

0 Comments

Share your thoughts